---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-016401"
form_type: "8-K"
ticker: "PRVA"
cik: "0001759655"
company_name: "Privia Health Group, Inc."
filed_at: "2023-05-08T23:59:59+00:00"
generated_at: "2026-06-15T13:51:35.125078+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Privia Health selling stockholders offer 42.56M shares; company receives no proceeds

## Summary
- Underwriting agreement with Goldman Sachs for secondary offering of 42,561,196 shares of common stock.
- Offering closed May 8, 2023; company received no proceeds from sale by selling stockholders.
- Registration statement on Form S-3ASR (File No. 333-268394) filed November 15, 2022, with prospectus supplement.
- Total estimated expenses of $595,185 for the issuance to be paid by the company.

## SEC filing metadata
- accession: 0001628280-23-016401
- form_type: 8-K
- ticker: PRVA
- cik: 0001759655
- company_name: Privia Health Group, Inc.
- filed_at: 2023-05-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1759655/000162828023016401/0001628280-23-016401-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1759655/000162828023016401/prva-20230504.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-016401
- JSON: https://secwatch.observer/filing/0001628280-23-016401.json
- Plain text: https://secwatch.observer/filing/0001628280-23-016401.txt

## Key facts
- Material Agreements
  Privia Health Group, Inc. entered into Underwriting Agreement with Goldman Sachs & Co. LLC (effective 2023-05-04).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: Goldman Sachs & Co. LLC
  - Effective: 2023-05-04
  source text: On May 4, 2023, Privia Health Group, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Goldman Sachs & Co. LLC as underwriter (the “Underwriter”) and the selling stockholders listed on Schedule I thereto (the “Selling Stockholders”) with respect to an underwritten offering by the Selling Stockholders of 42,561,196 shares (the “Shares”) of the Company’s common stock, par value $0.01 per share, held by such Selling Stockholders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1759655/000162828023016401/0001628280-23-016401-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.